Results 41 to 50 of about 422,131 (199)
Bacterial infections in patients with liver cirrhosis and ascites [PDF]
Srpski Arhiv za Celokupno Lekarstvo, 2014 Introduction. Bacterial infections are common complications and the cause of death in patients with cirrhosis and ascites. There is no standard method for a rapid and low-cost diagnosis, and its prognosis is poor. Objective.
Marković-Živković Bojana +6 more
doaj +1 more source
Can we prevent antimicrobial resistance by using antimicrobials better? [PDF]
, 2013 Since their development over 60 years ago, antimicrobials have become an integral part of healthcare practice worldwide. Recently, this has been put in jeopardy by the emergence of widespread antimicrobial resistance, which is one of the major problems ...
Brown +27 more
core +2 more sources
New antimicrobial agents for the treatment of Gram-positive bacterial infections [PDF]
Clinical Microbiology and Infection, 2008 Since the 1970s, resistance to antimicrobial agents has become an escalating problem. In the last 25 years, treatment of infections caused by Gram-positive bacteria has been more problematical than ever, with infections being caused by multidrug-resistant organisms, particularly methicillin-resistant staphylococci, penicillin- and erythromycin ...
Aksoy, D.Y., Unal, S.
openaire +4 more sources
Measures to eradicate multidrug-resistant organism outbreaks: How much does it cost? [PDF]
, 2015 This study aimed to assess the economic burden of infection control measures that succeeded in eradicating multidrug-resistant organisms (MDROs) in emerging epidemic contexts in hospital settings.
Birgand, GJC +6 more
core +1 more source
A new oxazolidinone antimicrobial [PDF]
, 2014 Purpose. The mechanism of action, pharmacokinetics, pharmacodynamics, and clinical efficacy and safety of an investigational second-generation oxazolidinone are reviewed. Summary. Tedizolid is a protein synthesis inhibitor in clinical development for the
Childs, Lindsay M, +3 more
core +1 more source
Novel Antibiotics for the Treatment of Gram-Positive Bacterial Infections
Journal of Medicinal Chemistry, 2002 The natural dipeptide antibiotic TAN 1057 A,B displays excellent antibacterial activity against staphylococci including methicillin resistant Staphylococcus aureus. However, the in vitro activity against additional Gram-positive strains, in particular pneumococci and Enterococcus faecalis, proved to be considerably lower.
Brands, M. +9 more
openaire +3 more sources
Dynamics of Mycobacterium tuberculosis Ag85B Revealed by a Sensitive Enzyme-Linked Immunosorbent Assay. [PDF]
, 2019 Secretion of specific proteins contributes to pathogenesis and immune responses in tuberculosis and other bacterial infections, yet the kinetics of protein secretion and fate of secreted proteins in vivo are poorly understood. We generated new monoclonal
Bolz, Miriam +2 more
core +2 more sources
Journal of Nepal Medical Association, 2022 Introduction: A hospital-based investigation of bacteriological isolates helps to identify common causative bacteria and their antibiotic sensitivity patterns.
Ishor Pradhan +4 more
doaj +1 more source
Enrofloxacin-based therapeutic strategy for the prevention of endometritis in susceptible mares [PDF]
, 2010 Enrofloxacin (EFX) is often used empirically to prevent uterine infections in mares in order to improve efficiency on Commercial Embryo Transfer Farms.
Confalonieri, Alejandra +7 more
core +1 more source
Frontiers in Microbiology, 2021 Infections caused by Gram-positive bacteria are a major public health problem due to their increasing resistance to antibiotics. Staphylococcus and Enterococcus species’ resistance and pathogenicity are enhanced by their ability to form biofilm.
Alessandra Oliva +3 more
doaj +1 more source